Aegerion’s representative in Argentina discusses her efforts to raise awareness of Homozygous Familial Hypercholesteremia (HoFH), the rare disease…

Gabriela Pittis discusses the Argentinian healthcare system's ability to diagnose, treat, and regulate rare diseases, and the country’s progress in…

Kenneth Y Hartigan-Go, Acting Director General of the Food and Drug Administration Philippines (FDA) discusses the current state of regulations…

The Chairman and CSO of TCM Biotech offer perspectives on the potential of botanical drugs, and chart their biotech company's trajectory in bringing…

Jaw-Jou Kang, former Director General of Taiwan Food & Drug Administration (TFDA) discusses the key successes the company has had since 2010,…

The Chairman of Taiwan Advance Bio-Pharmaceutical Inc. discusses the challenges and opportunities TABP has faced in its transformation into a…

As the only country in the G8 without an orphan drugs act, the president of Médunik, a company focused on bringing orphan drugs into the country,…

The CEO of Bellus Health outlines his strategy since 2010 to change the focus of the company from Alzheimer’s to a niche disease, AA amyloidosis, as…

BIOTECanada is the national trade association for Canada’s biotech industry. Andrew Casey, the group’s CEO, discusses the impact of IP regulation…

Could you begin by giving a short introduction to Nordic Drugs and its current position within the structure of owner Nordic Group? Nordic Drugs…

Mr. Mazeman, can you please begin by offering a brief overview of your career to date? I am a French pharmacist by training, with expertise in…

Pharmaceutical Executive, highlighting the milestones in the company development since you took over five years ago? Unilab is the biggest…